PF-07329640 is a humanized monoclonal antibody inhibitor targeting TNFRSF3. It is used in research on advanced or metastatic solid tumors, such as non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
